Preliminary Detailed Programme
Thursday 3 December 2020 |
||
09:00–
|
Postgraduate Session 1 |
B1+B2 |
| Diagnosis and Management of Functional Chest Pain Ronnie Fass, USA |
||
| Improving Neoplasia Detection Rate in Barrett's Esophagus Prateek Sharma, USA |
||
| H. pylori Treatment Strategies Henry Cohen, Uruguay |
||
| TBA | ||
| TBA | ||
09:00–
|
Plenary Session |
C1+C2 |
09:00–
|
Gut Microbiota in Gastrointestinal Health and Disease |
D8+D9 |
| TBA | ||
| Microbiota and Immune System Miloslav Kverka, Czech Republic |
||
| TBA | ||
| TBA | ||
| Intestinal Microbiota in IBS Mirjana Rajilić-Stojanović, Serbia |
||
09:00–
|
HCV Treatment as the Way to Elimination |
D6+D7 |
| TBA | ||
| DAAs as the Way to Global HCV Elimination Alessandra Mangia, Italy |
||
| The Burden of HCV and HIV Coinfection Robert Flisiak, Poland |
||
| Metabolic Changes in Chronic HCV Infection Peter Jarcuska, Slovakia |
||
| Improving Quality of Life after DAA Treatment Michael Makara, Hungary |
||
09:00–
|
Free papers 1 |
D3 |
09:00–
|
Free papers 2 |
D4 |
10:30–
|
Coffee break |
|
11:00–
|
Postgraduate Session 2 |
B1+B2 |
| Non-responsive Celiac Disease David Sanders, UK |
||
| Management of Small Bowel Polyps Jean-Christophe Saurin, France |
||
| Fecal Incontinence: Rome IV Criteria and Treatment Magnus Simren, Sweden |
||
| Critical Issues in Diverticular Disease Dan Dumitrascu, Romania |
||
| TBA | ||
11:00–
|
GI Oncology: Where Are We Going? |
C1+C2 |
| TBA | ||
| Individualized Therapy of GI Cancer: What is Here and What is to Come? Joseph Sung, China |
||
| TBA | ||
| Neoadjuvant Therapy for Operable Cancer: A Paradigm Shift? Thomas Seufferlein, Germany |
||
| TBA | ||
11:00–
|
Gut in Motion: News from Upper GI Motility Disorders |
D8+D9 |
| TBA | ||
| How to Diagnose and Classify Esophageal Motility Disorders Mark Fox, UK |
||
| How to Diagnose Gastroparesis – Scintigraphy, Capsule, Breath Test of Endoflip? Zuzana Vacková, Czech Republic |
||
| TBA | ||
| Endoscopic Treatment for Esophageal and Gastric Motility Disorders Marcel Tantau, Romania |
||
11:00–
|
Changing Face of Viral Hepatitis |
D6+D7 |
| TBA | ||
| Current Treatment Options of Hepatitis Delta Infection Cihan Yurdaydin, Turkey |
||
| Current Insight in HBV Reactivation Daniel Shouval, Israel |
||
| Increasing Burden of HEV Infection Krzysztof Tomasiewicz, Poland |
||
| TBA | ||
11:00–
|
Free papers 3 |
D3 |
11:00–
|
Free papers 4 |
D4 |
12:30–
|
Lunch / Lunch Symposium |
|
13:30–
|
Postgraduate Session 3 |
B1+B2 |
| TBA | ||
| Vaccination in Patients with IBD Gerhard Rogler, Switzerland |
||
| TBA | ||
| TBA | ||
| Endoscopic treatment of Acute Pancreatitis Tomáš Hucl, Czech Republic |
||
13:30–
|
CGS Session 1 – Onemocnění jater (in Czech) |
C1+C2 |
13:30–
|
Early Esophageal Cancer – Recent Advances |
D8+D9 |
| Diagnosis and Staging of Early Esophageal Neoplasia and Premalignant Conditions Peter Siersema, the Netherlands |
||
| Indication for Endoscopic Treatment Weusten Bas, the Netherlands |
||
| Indication for Surgery Tomáš Haruštiak, Czech Republic |
||
| TBA | ||
| Case Based Panel Discussion | ||
13:30–
|
Up-to date Approach to Biliary Stricture |
D6+D7 |
| Brush and FISH First Urban Arnelo, Sweden |
||
| Cholangioscopy First Yong Moon, South Korea |
||
| EUS First Ondřej Urban, Czech Republic |
||
| TBA | ||
| Stents Petr Vítek, Czech Republic |
||
13:30–
|
Free papers 5 |
D3 |
13:30–
|
Free papers 6 |
D4 |
15:00–
|
Coffee break |
|
15:30–
|
Postgraduate Session 4 |
B1+B2 |
| Biliary Endoscopy in the Management of Primary Sclerosing Cholangitis and Its Complications Nageshwar Reddy, India |
||
| TBA | ||
| Screening in HCC Guilherme Macedo, Portugal |
||
| New biomarkers in the management of viral hepatitis Cihan Yurdaydin, Turkey |
||
| Autoimmune Liver Disease Joost Drenth, the Netherlands |
||
15:30–
|
CGS Session 2 – Onemocnění pankreatu a žlučových cest (in Czech) |
C1+C2 |
15:30–
|
IBD and Other Immune-mediated Inflammatory Disorders |
D8+D9 |
| TBA | ||
| TBA | ||
| Therapeutic Consequences of IMID in IBD Patients Milan Lukáš, Czech Republic |
||
| TBA | ||
| IMID or Extraintestinal Manifestation of IBD? Tamás Molnár, Hungary |
||
15:30–
|
Acute Pancreatitis |
D6+D7 |
| Patomechanism of AP: A Critical Appraisal of Clinical Relevance Jason Bruce, UK |
||
| TBA | ||
| TBA | ||
| TBA | ||
| TBA | ||
15:30–
|
Free papers 7 |
D3 |
15:30–
|
Free papers 8 |
D4 |
17:00–
|
Opening Ceremony |
B1+B2 |
